Exploratory health economic analyses to support decisions within the innovation process in radiotherapy: Magnetic Resonance Linear Accelerator as a case study
Open Access
- 14 May 2025
- journal article
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 34, 100314
Abstract
No abstract availableKeywords
Funding Information
- Netherlands Organisation for Health Research and Development (10580012210015)
This publication has 13 references indexed in Scilit:
- Early health economic analysis of 1.5 T MRI-guided radiotherapy for localized prostate cancer: Decision analytic modellingRadiotherapy and Oncology, 2021
- The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive TherapyFrontiers in Oncology, 2020
- Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancerBritish Journal of Radiology, 2020
- Technology‐driven research for radiotherapy innovationMolecular Oncology, 2020
- Update of the Dutch manual for costing studies in health carePLOS ONE, 2017
- Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the LiteraturePharmacoEconomics, 2017
- R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation OncologyFrontiers in Oncology, 2017
- (Very) Early technology assessment and translation of predictive biomarkers in breast cancerCancer Treatment Reviews, 2017
- The Role of Professional Societies in Limiting Indication CreepJournal of General Internal Medicine, 2014
- The Magnetic Resonance Imaging–Linac SystemSeminars in Radiation Oncology, 2014